Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision label on the page has been updated from v3.6.3 to v3.6.4, indicating a small underlying update to the site. The visible study details and navigation remain unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows an updated Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor platform update to the study details page.SummaryDifference0.1%

- Check54 days agoChange DetectedRecruitment status updated to closed for the study. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading was standardized, and the site revision note updated to v3.6.0.SummaryDifference0.5%

- Check61 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page or its template. This update appears to be a metadata/versioning change rather than a modification to the study content or data presented.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page metadata rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.